ArticleEJHaem2024

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient.

Dasom Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.